Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endo International PLC (NASDAQ:ENDP)

50.09
Delayed Data
As of Feb 12
 +1.60 / +3.30%
Today’s Change
46.66
Today|||52-Week Range
96.58
-18.18%
Year-to-Date
No recent news for Endo International PLC.

Today’s Trading

Previous close48.49
Today’s open49.39
Day’s range47.66 - 50.19
Volume3,039,697
Average volume (3 months)4,567,259
Market cap$11.3B
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+18.84%
Earnings growth (this year)+6.11%
Earnings growth (next 5 years)+14.00%
Revenue growth (last year)+9.95%
P/E ratioNM
Price/Sales3.68
Price/Book3.25

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+2.82+4.19%
INCYIncyte Corp+2.85+4.35%
RDYDr.Reddy's Laborator...-0.42-0.99%
JAZZJazz Pharmaceuticals...+1.06+0.94%
Data as of 4:01pm ET, 02/12/2016

Financials

Next reporting dateFebruary 29, 2016
EPS forecast (this quarter)$1.26
Annual revenue (last year)$2.9B
Annual profit (last year)-$721.3M
Net profit margin-25.14%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Rajiv De Silva
SVP-Operations, Research &
Development Strategy
Robert J. Cobuzzi
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers